318010 Stock Chart & Stats
₩3450.00
₩30.00(0.88%)
―
--
Day’s Range― - ―
52-Week Range₩3,135.00 - ₩6,010.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)12.52K
Market Cap
₩26.43B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)7.3
Beta0.07
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,929,338
10 Day Avg. Volume18,110
30 Day Avg. Volume12,517
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)3,183,553.6
Revenue Forecast (FY)₩10.00T>
318010 FAQ
What was Pharmsville Co., Ltd.’s price range in the past 12 months?
Pharmsville Co., Ltd. lowest stock price was ₩3135.00 and its highest was ₩6010.00 in the past 12 months.
What is Pharmsville Co., Ltd.’s market cap?
Pharmsville Co., Ltd.’s market cap is ₩26.43B.
When is Pharmsville Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Pharmsville Co., Ltd.’s earnings last quarter?
Pharmsville Co., Ltd. released its earnings results on May 14, 2026. The company reported ₩155.917 earnings per share for the quarter, beating the consensus estimate of N/A by ₩155.917.
Is Pharmsville Co., Ltd. overvalued?
According to Wall Street analysts Pharmsville Co., Ltd.’s price is currently Undervalued.
Does Pharmsville Co., Ltd. pay dividends?
Pharmsville Co., Ltd. does not currently pay dividends.
What is Pharmsville Co., Ltd.’s EPS estimate?
Pharmsville Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmsville Co., Ltd. have?
Pharmsville Co., Ltd. has 7,929,338 shares outstanding.
What happened to Pharmsville Co., Ltd.’s price movement after its last earnings report?
Pharmsville Co., Ltd. reported an EPS of ₩155.917 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.994%.
Which hedge fund is a major shareholder of Pharmsville Co., Ltd.?
Currently, no hedge funds are holding shares in KR:318010
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Genematrix Inc.
―
SANIGEN Co., Ltd.
―
HLB bioStep Co.Ltd.
―
NGeneBio Co., Ltd.
―
TDSPharm Co., Ltd.
―